e-learning
resources
Barcelona 2013
Monday, 09.09.2013
New methods for diagnostic workup of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by multifactorial logistic regression analysis
M. Bukovskis, G. Strazda, N. Jurka, U. Kopeika, A. Pirtnieks, L. Balode, J. Aprinceva, I. Kantane, I. Taivans (Riga, Latvia)
Source:
Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Session:
New methods for diagnostic workup of lung cancer
Session type:
Thematic Poster Session
Number:
2889
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bukovskis, G. Strazda, N. Jurka, U. Kopeika, A. Pirtnieks, L. Balode, J. Aprinceva, I. Kantane, I. Taivans (Riga, Latvia). Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by multifactorial logistic regression analysis. Eur Respir J 2013; 42: Suppl. 57, 2889
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
LATE-BREAKING ABSTRACT: New algorithm of lung cancer diagnosis by analysis of exhaled breath with electronic nose and multifactorial logistic regression method
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014
Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013
Detection of early stage lung cancer by electronic nose
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013
Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Early diagnosis of lung cancer by the electronic nose: Preliminary results
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Detection of lung cancer using expired breath analysis by ion mobility spectrometry
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Breath collection related factors may influence electronic nose ability to detect lung cancer
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Evaluation of spirometry test as monitoring tool in lung cancer patients
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Smoking status affects VRI assissted prediction of postoperative FEV1 and D
L,CO
in patients with lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
Electronic nose as a screening tool for early stage lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Exhaled breath temperature in NSCLC: Could be a new non invasive marker?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Cardio-respiratory exercise testing in the pre-surgical evaluation of lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept